Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma

NCT06645678 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Refractory Multiple Myeloma (RRMM)

Interventions

DRUG: Elranatamab
DRUG: Mezigdomide
DRUG: Dexamethasone

Sponsor

YOUNGIL KOH